Prostate cancer trials in China

In China 252 Also abroad 1481

252 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Personalized Optimization of Systematic Prostate Biopsy
Where
Fuzhou
Age
50 years to 95 years
People
330
Run by
Fujian Medical University Union Hospital
See details and how to joinNCT05998278
Phase 2Not yet taking people in China
Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019
Where
Beijing
Age
18 years to 75 years
People
40
Run by
Peking University First Hospital
See details and how to joinNCT07282197
No phaseTaking people
MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)
Where
Beijing
Age
18 years and over
People
50
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT05183074
No phaseNot yet taking people in China
PSMA-PET/MRI-Ultrasound Multimodal Fusion Navigation for Da Vinci Robot-Assisted Radical Prostatectomy: A Randomized Controlled Trial
Where
Shanghai
Age
Up to 90 years
People
98
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07272317
Phase 2Not yet taking people in China
CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer
Where
Shanghai
Age
18 years to 70 years
People
112
Run by
Fudan University
See details and how to joinNCT07268794
Phase 1Taking people
Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer
Where
Shanghai
Age
18 years and over
People
63
Run by
Hansoh BioMedical R&D Company
See details and how to joinNCT07115446
Phase 2Taking people
A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer
Where
Nanjing
Age
18 years to 85 years
People
30
Run by
baotai Liang
See details and how to joinNCT07250542
No phaseTaking people
MR Microstructural Imaging for Prostate Cancer Diagnosis
Where
Beijing, Dalian, Hangzhou, Nanjing, Zhengzhou
People
2,000
Run by
First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07249281
No phaseTaking people
68Ga-XACP3 PET/CT in Prostate Cancer
Where
Xiamen
Age
18 years to 80 years
People
60
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07242014
No phaseNot yet taking people in China
Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer
Where
Beijing, Chengdu, Guangzhou, Nanjing, Ningbo, Shanghai, Suzhou
Age
18 years to 80 years
People
1,100
Run by
Shanghai Changzheng Hospital
See details and how to joinNCT07238959
Phase 2/3Taking people
Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer
Where
Nanjing
Age
18 years to 85 years
People
83
Run by
baotai Liang
See details and how to joinNCT06861192
Phase 2Taking people
Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study
Where
Nanjing
Age
18 years to 85 years
People
93
Run by
baotai Liang
See details and how to joinNCT07163910
Phase 2/3Taking people
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
Where
Fuzhou
Age
18 years to 80 years
People
100
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT07209878
Early phase 1Taking people
177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer
Where
Beijing
Age
18 years to 90 years
People
30
Run by
Peking Union Medical College Hospital
See details and how to joinNCT05603559
No phaseTaking people
68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients
Where
Beijing
Age
18 years to 90 years
People
50
Run by
Peking Union Medical College Hospital
See details and how to joinNCT05324332
Phase 2Taking people
Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)
Where
Tianjin
Age
18 years and over
People
28
Run by
Tianjin Medical University Second Hospital
See details and how to joinNCT07179783
Phase 1/2Not yet taking people in China
Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets
Where
Chongqing, Shanghai, Zhuhai
Age
18 years and over
People
291
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07172126
No phaseTaking people
Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC
Where
Jinan
Age
18 years and over
People
116
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07172685
No phaseEnrolling by invitation
Evaluation of [68Ga]DOTA-IR-780-C-4 in PET Imaging Studies for PSMA-Positive Prostate Cancer Patients
Where
Wuxi
Age
18 years to 80 years
People
5
Run by
Affiliated Hospital of Jiangnan University
See details and how to joinNCT07162779
Phase 2Taking people
Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer
Where
Nanjing, Nantong
Age
18 years to 85 years
People
96
Run by
baotai Liang
See details and how to joinNCT06834321
Phase 1/2Taking people
A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone
Where
Changsha, Hefei
Age
18 years and over
People
66
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT06689163
Phase 2Taking people
A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC
Where
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Hefei, Hunan, Jinan, Nanjing, Nantong, Ningbo, Shanghai, Shenyang, Tianjin, Wenzhou, Wuhan, Zhengzhou
Age
18 years and over
People
100
Run by
MediLink Therapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT06241846
No phaseTaking people
Efficacy and Safety of Radical Prostatectomy (RP) With or Without Salvage Radiotherapy Versus RP With Extended Pelvic Lymph Node Dissection for Localized Intermediate- and High-risk Prostate Cancer With a Briganti Nomogram≥7%
Where
Shanghai
Age
18 years to 80 years
People
270
Run by
Ruijin Hospital
See details and how to joinNCT07115992
Phase 2Taking people
Ivonescimab in the Treatment of Multiple Advanced Tumors
Where
Shanghai
Age
18 years and over
People
400
Run by
Fudan University
See details and how to joinNCT06683846
Phase 1Taking people
A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer
Where
Jinan
Age
18 years and over
People
40
Run by
Xiaorong Sun
See details and how to joinNCT07135102